Microbot Medical Files 8-K with Material Agreement Details
Ticker: MBOT · Form: 8-K · Filed: Jul 1, 2024 · CIK: 883975
| Field | Detail |
|---|---|
| Company | Microbot Medical Inc. (MBOT) |
| Form Type | 8-K |
| Filed Date | Jul 1, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, financials
TL;DR
Microbot Medical filed an 8-K on July 1st, confirming a material definitive agreement and providing financial updates.
AI Summary
On July 1, 2024, Microbot Medical Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes financial statements and exhibits, with the company's principal executive offices located at 288 Grove Street, Suite 388, Braintree, MA 02184.
Why It Matters
This filing indicates a significant contractual development for Microbot Medical Inc., which could impact its operations and future financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's financial health and stock performance.
Key Players & Entities
- Microbot Medical Inc. (company) — Registrant
- July 1, 2024 (date) — Date of earliest event reported
- 288 Grove Street , Suite 388 Braintree , MA 02184 (address) — Address of Principal Executive Offices
FAQ
What is the nature of the material definitive agreement filed by Microbot Medical Inc.?
The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the summary text.
When was this 8-K filing submitted?
The filing was made on July 1, 2024, which is also the date of the earliest event reported.
Where are Microbot Medical Inc.'s principal executive offices located?
The principal executive offices are located at 288 Grove Street, Suite 388, Braintree, MA 02184.
What is Microbot Medical Inc.'s state of incorporation and SEC file number?
Microbot Medical Inc. is incorporated in Delaware and has an SEC file number of 000-19871.
Does this filing include financial statements?
Yes, the filing explicitly states that it includes 'Financial Statements and Exhibits'.
Filing Stats: 928 words · 4 min read · ~3 pages · Grade level 10.6 · Accepted 2024-07-01 16:36:20
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value MBOT NASDAQ Capital Mark
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex5-1.htm (EX-5.1) — 14KB
- ex10-1.htm (EX-10.1) — 50KB
- ex5-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-24-025813.txt ( ) — 296KB
- mbot-20240701.xsd (EX-101.SCH) — 3KB
- mbot-20240701_lab.xml (EX-101.LAB) — 33KB
- mbot-20240701_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MICROBOT MEDICAL INC. By: /s/ Harel Gadot Name: Harel Gadot Title: Chief Executive Officer, President and Chairman Dated: July 1, 2024